Trial Profile
Cost-minimization Analysis of Xeloda vs 5-fluorouracil-based Treatment for Gastric Cancer Patients in Hong Kong
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2024
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Epirubicin; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 12 Sep 2012 New trial record